Prevention of anal condyloma with quadrivalent human papillomavirus vaccination of older men who have sex with men

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Swedish, Kristin A ^a   Goldstone, Stephen E ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGED; ANAL CONDYLOMA; ANUS DISEASE; ARTICLE; COHORT ANALYSIS; CONDYLOMA; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PAPILLOMAVIRUS INFECTION; POST HOC ANALYSIS; RISK REDUCTION; VACCINATION; ALPHAPAPILLOMAVIRUS; ANUS DISEASES; CONDYLOMATA ACUMINATA; ISOLATION AND PURIFICATION; MALE HOMOSEXUALITY; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; VIROLOGY;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; ANUS DISEASES; COHORT STUDIES; CONDYLOMATA ACUMINATA; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES;

EID: 84899568791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093393     Document Type: Article

References (20)

1. Genital HPV infection - fact sheet. Available: http://www.cdc.gov/std/ HPV/STDFact-HPV.htm. Accessed 2013 Jun 22.
2. Anic GM, Lee JH, Villa LL, Lazcano-Ponce E, Gage C, et al. (2012) Risk factors for incident condyloma in a multinational cohort of men: The HIM Study. J Infect Dis 205: 789-793.
3. Howley PM, Lowy DR (2007) Papillomaviruses. In: Knipe DM, Howley PM, editors. Field's Virology. Philadelphia, PA: Lippincott Williams & Wilcons. 2299-2354.
4. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Aranda C, et al. (2011) Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 364: 401-411.
5. Centers for Disease Control and Prevention (2010) FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morbid Mortal Week 59: 630-632.
6. Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, et al. (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. NEJM 365: 1576-1585.
7. Goldstone SE, Jessen H, Palefsky JM, Giuliano AR, Moreira ED Jr, et al. (2013) Quadrivalent HPV vaccine efficacy against disease related to vaccine and nonvaccine HPV types in males. Vaccine 31: 3849-3855.
8. Van Den Eeden SK, Habel LA, Sherman KJ, McKnight B, Stergachis A, et al. (1998) Risk factors for incident and recurrent condylomata among men: A population-based study. Sex Transm Dis 25: 278-284. (Pubitemid 28309064)
9. Jin F, Prestage GP, Kippax SC, Pell CM, Donovan B, et al. (2007) Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: The HIM study. Sex Transm Dis 34: 488-493. (Pubitemid 46987957)
10. Lee Mortensen G, Larsen HK (2010) Quality of life of homosexual males with genital warts: A qualitative study. BMC Res Notes 3: 280.
11. Chesson HW, Ekwueme DU, Saraiya M, Watson M, Lowy DR, et al. (2012) Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine 42: 6016-6019.
12. D'Ambrogio A, Yerly S, Sahli R, Bouzourene H, Demarines N, et al. (2009) Human papilloma virus type and recurrence rate after surgical clearance of anal condylomata acuminata. Sex Transm Dis 36: 536-540.
13. Mistrangelo M, Cornaglia S, Pizzio M, Rimonda R, Gavello G, et al. (2010) Immunostimulation to reduce recurrence after surgery for anal condyloma acuminate: A prospective randomized controlled trial. Colorectal Dis 12: 799-803.
14. Swedish KA, Factor SH, Goldstone SE (2012) Prevention of recurrent highgrade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: A nonconcurrent cohort study. Clin Infect Dis 54: 891-898.
15. Swedish KA, Lee EQ, Goldstone SE (2011) The changing picture of high-grade anal intraepithelial neoplasia in men who have sex with men: The effects of 10 years of experience performing high-resolution anoscopy. Dis Colon Rectum 13: 1003-1007.
16. Chin-Hong PV, Vittinghoff E, Cranston RD, Buchbinder S, Cohen D, et al. (2004) Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: The EXPLORE study. J Infect Dis 190: 2070-2076. (Pubitemid 39636353)
17. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, et al. (2008) Acquisition of anal human papillomavirus infection in women: the Hawaii HPV cohort study. J Infect Dis 197: 957-966. (Pubitemid 351590023)
18. Shvetsov YB, Hernandez BY, McDuffie K, Wilkens LR, Zhu X, et al. (2009) Duration and clearance of anal human papillomavirus infection among women: the Hawaii HPV cohort study. Clin Infect Dis 48: 536-546.
19. Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, et al. (2012) Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: Retrospective pooled analysis of trial data. BMJ 344: e1401.
20. Thomas EA, Goldstone SE (2011) Should I or shouldn't I: decision making, knowledge and behavioral effects of quadrivalent HPV vaccination in men who have sex with men. Vaccine 29: 570-576.